Back to News

Functional Assessment of Fatigue and Other Patient-Reported Outcomes in Patients Enrolled in the Global aHUS Registry

[vc_row][vc_column][vc_single_image image=”7211″ img_size=”large” alignment=”center” label=””][vc_column_text]This longitudinal studyassessedfatigue and treatment status in patients with Atypical hemolytic uremic syndrome (aHUS) from the Global aHUS Registry.

The results confirm the detrimental effects of aHUS on patients’ daily lives, especially in terms of fatigue,butdemonstratessignificant improvement in symptoms following treatment with eculizumab.[/vc_column_text][/vc_column][/vc_row]

Help us advance kidney health worldwide
Join the ISN
Back to News